AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 11020506 — intervention group
Group type: COMPARATOR
Intervention: TDT catheter
Number of subjects: 66
Study 9816202 — intervention group
Group type: COMPARATOR
Intervention: Carboplatin alone
Number of subjects: 11
Study 9816202 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboplatin following Taxol pretreatment
Number of subjects: 11
Study 1482300 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium cromoglycate (SCG) nebulized solution
Number of subjects: 31
Study 1482300 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline solution)
Number of subjects: 31
Study 3516509 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenylpropanolamine OROS (Acutrim)
Number of subjects: 106
Study 3516509 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 106
Study 30222804 — intervention group
Group type: EXPERIMENTAL
Intervention: CLS‐TA (triamcinolone acetonide injectable suspension)
Number of subjects: 14
Study 30222804 — intervention group
Group type: COMPARATOR
Intervention: Fellow eyes (control group)
Number of subjects: 14
Study 27287210 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline (oral, 4 weeks)
Number of subjects: 173
Study 27287210 — intervention group
Group type: COMPARATOR
Intervention: Placebo (oral, 4 weeks)
Number of subjects: 173
Study 27287210 — intervention group
Group type: EXPERIMENTAL
Intervention: Alclometasone (topical) plus VSL#3 (oral)
Number of subjects: 173
Study 27287210 — intervention group
Group type: EXPERIMENTAL
Intervention: VSL#3 (oral)
Number of subjects: 173
Study 27287210 — intervention group
Group type: COMPARATOR
Intervention: Placebo (for alclometasone and VSL#3)
Number of subjects: 173
Study 25241229 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemoradiotherapy (CHRT) with fluorouracil (5 FU) infusion and cisplatin, associated with radiotherapy (50 Gy)
Number of subjects: 34
Study 25241229 — intervention group
Group type: COMPARATOR
Intervention: Gemcitabine plus oxaliplatin (GEMOX) for 6 months (CH arm)
Number of subjects: 34
Study 22857987 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental practice in addition to occupational therapy
Number of subjects: 30
Study 19858313 — intervention group
Group type: EXPERIMENTAL
Intervention: Project ACTS educational materials
Number of subjects: 425
Study 19858313 — intervention group
Group type: COMPARATOR
Intervention: Donation education materials currently available to consumers
Number of subjects: 425
Study 18376338 — intervention group
Group type: EXPERIMENTAL
Intervention: Repetitive Transcranial Magnetic Stimulation (rTMS) at 1 Hz, 1200 stim/day for five days
Number of subjects: 0
Study 18376338 — intervention group
Group type: COMPARATOR
Intervention: Placebo control
Number of subjects: 0
Study 16398602 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-minute forearm/hand massage of effleurage and friction
Number of subjects: 52
Study 16398602 — intervention group
Group type: COMPARATOR
Intervention: 5 minutes of passive shoulder and elbow range of motion
Number of subjects: 52
Study 16398602 — intervention group
Group type: COMPARATOR
Intervention: 5 minutes of nonintervention rest
Number of subjects: 52
Study 12551706 — intervention group
Group type: EXPERIMENTAL
Intervention: Levodopa/benserazide (200/50 mg) with a high-fat breakfast
Number of subjects: 19
Study 12551706 — intervention group
Group type: COMPARATOR
Intervention: Levodopa/benserazide (200/50 mg) in fasting conditions
Number of subjects: 19
Study 12551706 — intervention group
Group type: EXPERIMENTAL
Intervention: Levodopa/benserazide (200/50 mg) with food
Number of subjects: 19
Study 10513411 — intervention group
Group type: EXPERIMENTAL
Intervention: Telviran (800 mg acyclovir)
Number of subjects: 24
Study 10513411 — intervention group
Group type: COMPARATOR
Intervention: Zovirax (800 mg acyclovir)
Number of subjects: 24
Study 7884432 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxorubicin
Number of subjects: 0
Study 2028627 — intervention group
Group type: EXPERIMENTAL
Intervention: SR PPA 75 mg/d
Number of subjects: 14
Study 2028627 — intervention group
Group type: COMPARATOR
Intervention: Indomethacin and placebo
Number of subjects: 14
Study 6106501 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined sedative and anxiolytic preparations (specific combinations not detailed)
Number of subjects: 0
Study 6106501 — intervention group
Group type: EXPERIMENTAL
Intervention: Amylobarbitone sodium (established hypnotic)
Number of subjects: 0
Study 6106501 — intervention group
Group type: EXPERIMENTAL
Intervention: Clobazam/dichloralphenazone (anxiolytic/sedative combination)
Number of subjects: 0
Study 30467827 — intervention group
Group type: EXPERIMENTAL
Intervention: i-gel
Number of subjects: 176
Study 30467827 — intervention group
Group type: COMPARATOR
Intervention: LMA Protector
Number of subjects: 176
Study 28675660 — intervention group
Group type: EXPERIMENTAL
Intervention: First-line intercalated chemotherapy + erlotinib, maintenance erlotinib in patients with EGFR mutations
Number of subjects: 56
Study 28675660 — intervention group
Group type: EXPERIMENTAL
Intervention: First-line afatinib, maintenance afatinib in patients with EGFR deletion 19
Number of subjects: 56
Study 28675660 — intervention group
Group type: EXPERIMENTAL
Intervention: First-line chemotherapy + bevacizumab, maintenance bevacizumab in EGFR wild-type patients
Number of subjects: 56
Study 28675660 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy + conatumumab, maintenance conatumumab in patients with squamous histology
Number of subjects: 56
Study 28675660 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy + cetuximab, maintenance cetuximab or chemotherapy + necitumumab, maintenance necitumumab in EGFR FISH-positive patients with squamous histology
Number of subjects: 56
Study 28675660 — intervention group
Group type: EXPERIMENTAL
Intervention: First-line chemotherapy + bevacizumab, maintenance bevacizumab or first-line sequential chemotherapy + gefitinib, maintenance gefitinib in patients clinically enriched for EGFR mutations with nonsquamous histology
Number of subjects: 56
Study 28675660 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 56
Study 26393645 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-carbohydrate diet (<40 g/day), n = 75
Number of subjects: 148
Study 26393645 — intervention group
Group type: COMPARATOR
Intervention: Low-fat diet (<30% kcal/day from total fat, <7% saturated fat), n = 73
Number of subjects: 148
Study 23531208 — intervention group
Group type: EXPERIMENTAL
Intervention: RBC transfusion of more than 3 units (high transfusion requirement group, 62 patients)
Number of subjects: 502
Study 23531208 — intervention group
Group type: EXPERIMENTAL
Intervention: RBC transfusion of 3 units or fewer (low transfusion requirement group, 241 patients)
Number of subjects: 502
Study 23531208 — intervention group
Group type: COMPARATOR
Intervention: No RBC transfusion (199 patients)
Number of subjects: 502
Study 20608806 — intervention group
Group type: EXPERIMENTAL
Intervention: Breastfeeding education/support offered at home on day 3 postpartum
Number of subjects: 60
Study 20608806 — intervention group
Group type: COMPARATOR
Intervention: Standard breastfeeding education provided to all women in the hospital (control group)
Number of subjects: 60
Study 19574500 — intervention group
Group type: EXPERIMENTAL
Intervention: Preinduced quadriceps fatigue (via electrostimulation-induced contractions)
Number of subjects: 24
Study 19574500 — intervention group
Group type: COMPARATOR
Intervention: Fresh state (no quadriceps fatigue)
Number of subjects: 24
Study 17295728 — intervention group
Group type: EXPERIMENTAL
Intervention: Needle acupuncture
Number of subjects: 109
Study 17295728 — intervention group
Group type: COMPARATOR
Intervention: Aromatherapy
Number of subjects: 109
Study 15385382 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal clonidine 37.5 microg (Group 2)
Number of subjects: 80
Study 15385382 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal clonidine 75 microg (Group 3)
Number of subjects: 80
Study 15385382 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal clonidine 150 microg (Group 4)
Number of subjects: 80
Study 15385382 — intervention group
Group type: COMPARATOR
Intervention: Isobaric 0.5% bupivacaine, 18 mg plus saline (Group 1, control)
Number of subjects: 80
Study 11350502 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.01% P‐113 mouthrinse
Number of subjects: 159
Study 11350502 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05% P‐113 mouthrinse
Number of subjects: 159
Study 11350502 — intervention group
Group type: COMPARATOR
Intervention: Placebo mouthrinse
Number of subjects: 159
Study 9699431 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-controlled TENS at the injection site
Number of subjects: 100
Study 9699431 — intervention group
Group type: COMPARATOR
Intervention: Topical anaesthesia (2 min application of 20% benzocaine)
Number of subjects: 100
Study 9699431 — intervention group
Group type: COMPARATOR
Intervention: No pretreatment
Number of subjects: 100
Study 7987557 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to coal and rock dust
Number of subjects: 0
Study 7987557 — intervention group
Group type: EXPERIMENTAL
Intervention: Biochemical tests
Number of subjects: 0
Study 2513630 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimethoprim-sulfamethoxazole (TMP-SMZ) prophylactically
Number of subjects: 0
Study 2513630 — intervention group
Group type: EXPERIMENTAL
Intervention: TMP-SMZ plus colistin
Number of subjects: 0
Study 2513630 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin alone
Number of subjects: 0
Study 2513630 — intervention group
Group type: COMPARATOR
Intervention: Neomycin plus colistin
Number of subjects: 0
Study 2513630 — intervention group
Group type: COMPARATOR
Intervention: Nonabsorbable agents
Number of subjects: 0
Study 1269214 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental soft gelatin formulations of digoxin in solution
Number of subjects: 0
Study 1269214 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsules of digoxin
Number of subjects: 0
Study 1269214 — intervention group
Group type: COMPARATOR
Intervention: Tablets of digoxin
Number of subjects: 0
Study 31698889 — intervention group
Group type: EXPERIMENTAL
Intervention: Visnadine Emulgel
Number of subjects: 15
Study 31698889 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 27809380 — intervention group
Group type: EXPERIMENTAL
Intervention: Encapsulated placenta (n = 10)
Number of subjects: 23
Study 27809380 — intervention group
Group type: COMPARATOR
Intervention: Beef placebo (n = 13)
Number of subjects: 23
Study 25686254 — intervention group
Group type: EXPERIMENTAL
Intervention: Technical training programme for the non-preferred foot
Number of subjects: 71
Study 25686254 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific training)
Number of subjects: 71
Study 23135877 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent Management Training‐Oregon Model (PMTO)
Number of subjects: 96
Study 23135877 — intervention group
Group type: COMPARATOR
Intervention: Wait-list condition (WLC)
Number of subjects: 96
Study 21621193 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard tongue-training task (1 hour with fixed training parameters)
Number of subjects: 44
Study 21621193 — intervention group
Group type: EXPERIMENTAL
Intervention: Modulation tongue-training task (1 hour with modulation of training parameters every 20 min)
Number of subjects: 44
Study 21621193 — intervention group
Group type: COMPARATOR
Intervention: Ability to roll the tongue
Number of subjects: 44
Study 17964548 — intervention group
Group type: EXPERIMENTAL
Intervention: Venlafaxine treatment
Number of subjects: 15
Study 17964548 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 15
Study 16816536 — intervention group
Group type: EXPERIMENTAL
Intervention: LV5FU2
Number of subjects: 294
Study 16816536 — intervention group
Group type: EXPERIMENTAL
Intervention: ldLV5FU2
Number of subjects: 294
Study 16816536 — intervention group
Group type: EXPERIMENTAL
Intervention: HD-FU
Number of subjects: 294
Study 16816536 — intervention group
Group type: EXPERIMENTAL
Intervention: Tomudex
Number of subjects: 294
Study 12615868 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftazidime 2 g every 8 h (C3 x 2)
Number of subjects: 81
Study 12615868 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftazidime 2 g as a loading dose, followed by ceftazidime 2 g over 7 h every 12 h (C2 x 2)
Number of subjects: 81
Study 10669372 — intervention group
Group type: EXPERIMENTAL
Intervention: Meningococcal C conjugate (MCC) vaccine
Number of subjects: 0
Study 10669372 — intervention group
Group type: COMPARATOR
Intervention: Meningococcal AC polysaccharide (MACP) vaccine
Number of subjects: 0
Study 9119865 — intervention group
Group type: EXPERIMENTAL
Intervention: Wrought Co‐28Cr‐6Mo‐0.2C metal‐on‐metal articulations
Number of subjects: 55
Study 9119865 — intervention group
Group type: COMPARATOR
Intervention: Ceramic‐on‐polyethylene hips (control group)
Number of subjects: 55
Study 8229139 — intervention group
Group type: EXPERIMENTAL
Intervention: Reg A (based on the Berlin‐Frankfurt‐Münster 1976 regimen)
Number of subjects: 545
Study 8229139 — intervention group
Group type: EXPERIMENTAL
Intervention: Reg B (the New York regimen)
Number of subjects: 545
Study 8229139 — intervention group
Group type: COMPARATOR
Intervention: Reg C (control regimen)
Number of subjects: 545
Study 3536495 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose (1g/kg body weight) 45 min before exercise
Number of subjects: 6
Study 3536495 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycerol (1g/kg body weight) 45 min before exercise
Number of subjects: 6
Study 3536495 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 3536495 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycerol and Glucose
Number of subjects: 6
Study 3536495 — intervention group
Group type: EXPERIMENTAL
Intervention: All dietary treatments
Number of subjects: 6
Study 29883984 — intervention group
Group type: EXPERIMENTAL
Intervention: Wearing a white coat (WC) during postpartum rounds
Number of subjects: 178
Study 29883984 — intervention group
Group type: COMPARATOR
Intervention: Not wearing a white coat (no-WC) during postpartum rounds
Number of subjects: 178
Study 29897589 — intervention group
Group type: COMPARATOR
Intervention: Lubiprostone (for phenanthrene opioids)
Number of subjects: 1296
Study 29897589 — intervention group
Group type: COMPARATOR
Intervention: Lubiprostone (for phenylpiperidine opioids)
Number of subjects: 1296
Study 29897589 — intervention group
Group type: COMPARATOR
Intervention: Lubiprostone (for diphenylheptane opioids)
Number of subjects: 1296
Study 26414626 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of oxytocin and motherwort injection
Number of subjects: 165
Study 26414626 — intervention group
Group type: COMPARATOR
Intervention: Oxytocin
Number of subjects: 165
Study 24814852 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral pedicle screw instrumentation
Number of subjects: 65
Study 24814852 — intervention group
Group type: COMPARATOR
Intervention: Bilateral pedicle screw instrumentation
Number of subjects: 65
Study 22926137 — intervention group
Group type: EXPERIMENTAL
Intervention: Normoxia (21% O2) during low-intensity exercise (40% Wmax)
Number of subjects: 10
Study 22926137 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoxia (16% O2) during low-intensity exercise (40% Wmax)
Number of subjects: 10
Study 22926137 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperoxia (100% O2) during low-intensity exercise (40% Wmax)
Number of subjects: 10
Study 22926137 — intervention group
Group type: COMPARATOR
Intervention: Comparison of MCAv and PCAv between 40 and 80% Wmax with normoxia
Number of subjects: 10
Study 22926137 — intervention group
Group type: COMPARATOR
Intervention: Comparison of MCAv and PCAv at 60% Wmax with hypoxia and hyperoxia
Number of subjects: 10
Study 20728288 — intervention group
Group type: EXPERIMENTAL
Intervention: Heroin (diacetylmorphine)
Number of subjects: 938
Study 20728288 — intervention group
Group type: COMPARATOR
Intervention: Methadone
Number of subjects: 938
Study 20728288 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychoeducation (PSE)
Number of subjects: 938
Study 20728288 — intervention group
Group type: COMPARATOR
Intervention: Case Management (CM)
Number of subjects: 938
Study 17513653 — intervention group
Group type: EXPERIMENTAL
Intervention: Liposome-encapsulated 1% ropivacaine
Number of subjects: 30
Study 17513653 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% plain ropivacaine
Number of subjects: 30
Study 17513653 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5% lidocaine and 2.5% prilocaine mixture (EMLA)
Number of subjects: 30
Study 17513653 — intervention group
Group type: EXPERIMENTAL
Intervention: 20% benzocaine gel
Number of subjects: 30
Study 16393717 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive educational intervention (INT)
Number of subjects: 0
Study 16393717 — intervention group
Group type: COMPARATOR
Intervention: Control standard asthma education (CON)
Number of subjects: 0
Study 12564951 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-current, long-duration iontophoresis (approximately 0.1 mA)
Number of subjects: 0
Study 12564951 — intervention group
Group type: COMPARATOR
Intervention: Higher-current, shorter-duration iontophoresis (1.5-4.0 mA)
Number of subjects: 0
Study 10357333 — intervention group
Group type: EXPERIMENTAL
Intervention: Granisetron 40 microg/kg
Number of subjects: 100
Study 10357333 — intervention group
Group type: COMPARATOR
Intervention: Perphenazine 70 microg/kg
Number of subjects: 100
Study 8889352 — intervention group
Group type: EXPERIMENTAL
Intervention: Low goal MAP < or = 92 mm Hg
Number of subjects: 94
Study 8889352 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual goal MAP 102-107 mm Hg
Number of subjects: 94
Study 8889352 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol, Amlodipine, or Enalapril (three antihypertensive drug regimens)
Number of subjects: 94
Study 8889352 — intervention group
Group type: EXPERIMENTAL
Intervention: Attendance at scheduled monthly follow-up visits
Number of subjects: 94
Study 8889352 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall attendance and medication adherence
Number of subjects: 94
Study 1984386 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 or 80 micrograms of rgp 160
Number of subjects: 72
Study 1984386 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 micrograms of hepatitis B vaccine
Number of subjects: 72
Study 1984386 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study 6684932 — intervention group
Group type: EXPERIMENTAL
Intervention: i.v. infusion of 20 mg diltiazem in 20 min
Number of subjects: 6
Study 6684932 — intervention group
Group type: EXPERIMENTAL
Intervention: peroral solution of 120 mg diltiazem
Number of subjects: 6
Study 6684932 — intervention group
Group type: COMPARATOR
Intervention: two 60 mg tablets of diltiazem (Dilzem)
Number of subjects: 6
Study 31381878 — intervention group
Group type: EXPERIMENTAL
Intervention: Woman's Condom (WC) in efficacy substudy
Number of subjects: 503
Study 31381878 — intervention group
Group type: COMPARATOR
Intervention: Woman's Condom (WC) in functionality study
Number of subjects: 503
Study 29681015 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryotherapy (cooled glove/sock worn for 15 min before, during, and after paclitaxel infusion)
Number of subjects: 29
Study 29681015 — intervention group
Group type: COMPARATOR
Intervention: Cryotherapy (cooled glove/sock)
Number of subjects: 29
Study 26103920 — intervention group
Group type: EXPERIMENTAL
Intervention: Familias Preparando la Nueva Generación (FPNG) + keepin'it REAL (kiR)
Number of subjects: 267
Study 26103920 — intervention group
Group type: COMPARATOR
Intervention: keepin'it REAL (kiR)
Number of subjects: 267
Study 25516315 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics three times daily for 8 days
Number of subjects: 100
Study 25516315 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics
Number of subjects: 100
Study 25516315 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 24122637 — intervention group
Group type: EXPERIMENTAL
Intervention: Nobori stent with biolimus A9
Number of subjects: 22
Study 20678136 — intervention group
Group type: EXPERIMENTAL
Intervention: Vertical augmentation with anorganic bovine bone blocks and delayed 5-month placement of ≥10 mm implants
Number of subjects: 60
Study 20678136 — intervention group
Group type: COMPARATOR
Intervention: 7-mm-long implants
Number of subjects: 60
Study 20678136 — intervention group
Group type: EXPERIMENTAL
Intervention: Vertical augmentation with anorganic bovine bone blocks
Number of subjects: 60
Study 20678136 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study 17953635 — intervention group
Group type: EXPERIMENTAL
Intervention: Etoricoxib (selective COX-2 inhibitor)
Number of subjects: 17
Study 17953635 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 16371185 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium carbonate/cholecalciferol therapy (calcium carbonate: 1500 mg per day; cholecalciferol 400 UI per day)
Number of subjects: 120
Study 16371185 — intervention group
Group type: COMPARATOR
Intervention: Calcium lactogluconate/calcium carbonate (mg 300 per day)
Number of subjects: 120
Study 12168172 — intervention group
Group type: EXPERIMENTAL
Intervention: Biosem plug
Number of subjects: 93
Study 12168172 — intervention group
Group type: EXPERIMENTAL
Intervention: Cemlock plug
Number of subjects: 93
Study 12168172 — intervention group
Group type: EXPERIMENTAL
Intervention: Thackray plug
Number of subjects: 93
Study 10424696 — intervention group
Group type: EXPERIMENTAL
Intervention: White noise
Number of subjects: 0
Study 10424696 — intervention group
Group type: COMPARATOR
Intervention: Silence
Number of subjects: 0
Study 8555805 — intervention group
Group type: EXPERIMENTAL
Intervention: Full health check (health education with feedback on cholesterol concentration and risk score)
Number of subjects: 1632
Study 8555805 — intervention group
Group type: EXPERIMENTAL
Intervention: Full health check
Number of subjects: 1632
Study 2106714 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclic estradiol-desogestrel therapy for 6 months
Number of subjects: 26
Study 2106714 — intervention group
Group type: COMPARATOR
Intervention: Non-climacteric control group
Number of subjects: 26
Study 7457591 — intervention group
Group type: EXPERIMENTAL
Intervention: Cutaneous icing
Number of subjects: 12
Study 7457591 — intervention group
Group type: EXPERIMENTAL
Intervention: Cutaneous brushing
Number of subjects: 12
Study 7457591 — intervention group
Group type: COMPARATOR
Intervention: Placebo conditions
Number of subjects: 12
Study 31268132 — intervention group
Group type: EXPERIMENTAL
Intervention: Tubaramure program (food-assisted multisectoral nutrition program)
Number of subjects: 60